Voloridge Investment Management
WGS icon

Voloridge Investment Management’s GeneDx Holdings WGS Stock Holding History

Voloridge Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-61,012
Closed -$5.4M – 1410
2025
Q1 		$5.4M Sell
61,012
-160,085
-72% -$13.9M 0.02% 756
2024
Q4 		$17M Sell
221,097
-3,285
-1% -$229K 0.06% 400
2024
Q3 		$9.52M Buy
+224,382
New +$7.58M 0.03% 600

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Voloridge Investment Management's WGS Position: Q2 2025 in Review

Voloridge Investment Management sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 61,012 shares — an estimated $5.4M sold.

Voloridge Investment Management first reported a position in WGS in Q3 2024 and held it in 3 quarters. The position peaked at $17M in Q4 2024. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

  • Voloridge Investment Management reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 61,012 GeneDx Holdings shares in Q2 2025, an estimated $5.4M.
  • Voloridge Investment Management first reported a position in GeneDx Holdings in Q3 2024 and held it in 3 quarters.
  • Voloridge Investment Management's GeneDx Holdings position peaked at $17M in Q4 2024.
  • 231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.